KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias.

The clinical features of long QT syndrome result from episodic life-threatening cardiac arrhythmias, specifically the polymorphic ventricular tachycardia torsades de pointes. KVLQT1 has been established as the human chromosome 11-linked gene responsible for more than 50% of inherited long QT syndrome. Here we describe the cloning of a full-length KVLQT1 cDNA and its functional expression. KVLQT1 encodes a 676-amino acid polypeptide with structural characteristics similar to voltage-gated potassium channels. Expression of KvLQT1 in Xenopus oocytes and in human embryonic kidney cells elicits a rapidly activating, K+-selective outward current. The I(Kr)-specific blockers, E-4031 and dofetilide, do not inhibit KvLQT1, whereas clofilium, a class III antiarrhythmic agent with the propensity to induce torsades de pointes, substantially inhibits the current. Elevation of cAMP levels in oocytes nearly doubles the amplitude of KvLQT1 currents. Coexpression of minK with KvLQT1 results in a conductance with pharmacological and biophysical properties more similar to I(Ks) than other known delayed rectifier K+ currents in the heart.

[1]  A. George,et al.  Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.

[2]  M. Tamkun,et al.  Molecular physiology of cardiac potassium channels. , 1996, Physiological reviews.

[3]  R. Stein,et al.  Cloning and expression of the delayed-rectifier IsK channel from neonatal rat heart and diethylstilbestrol-primed rat uterus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Colatsky,et al.  Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. , 1990, Circulation.

[5]  D. Roden,et al.  Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone. , 1991, Circulation research.

[6]  M. Sanguinetti,et al.  Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. , 1993, Circulation research.

[7]  Arthur J Moss,et al.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.

[8]  M. Sanguinetti,et al.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents , 1990, The Journal of general physiology.

[9]  R Lazzara,et al.  Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.

[10]  B. Attali,et al.  Cytoplasmic and Extracellular IsK Peptides Activate Endogenous K and Cl Channels in Xenopus Oocytes , 1996, The Journal of Biological Chemistry.

[11]  M. Sanguinetti,et al.  Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Green,et al.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.

[13]  A. Feinberg,et al.  Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements , 1997, Nature Genetics.

[14]  B. Horowitz,et al.  Expression of cystic fibrosis transmembrane regulator Cl- channels in heart. , 1992, Circulation research.

[15]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[16]  S Nattel,et al.  Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. , 1993, Circulation research.

[17]  S. Baylin,et al.  Epigenetics and human disease , 1996, Nature Medicine.

[18]  Jacques Barhanin,et al.  KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.

[19]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[20]  M. Sanguinetti,et al.  Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel , 1996, Nature.

[21]  D. Snyders,et al.  High affinity open channel block by dofetilide of HERG expressed in a human cell line. , 1996, Molecular pharmacology.

[22]  M. Lazdunski,et al.  Cloning, expression, pharmacology and regulation of a delayed rectifier K+ channel in mouse heart. , 1991, The EMBO journal.

[23]  R. Kass,et al.  Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked. , 1988, Molecular pharmacology.

[24]  L. Kaczmarek,et al.  Modulation by cAMP of a slowly activating potassium channel expressed in Xenopus oocytes , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  J. Adelman,et al.  The min K channel underlies the cardiac potassium current IKs and mediates species-specific responses to protein kinase C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Kass,et al.  The roles of ion channels in an inherited heart disease: molecular genetics of the long QT syndrome. , 1996, Cardiovascular research.